New England Breast Cancer Alliances mission is to provide resources towards breast cancer research, with the long term goals of contributing to improvements in disease detection, treatment, and ultimately survival rates among women in Maine, New England, and elsewhere. Additionally, to connect and provide support to those facing breast cancer.
Reported officers (all unpaid)
No paid executives reported in 2023. New England Breast Cancer Alliance reported 7 unpaid officers and board members on its 990.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
What Public & Societal Benefit executives earn
New England Breast Cancer Alliance reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable public & societal benefit organization nationwide earns a median of $83,690.
These are public & societal benefit sector-wide figures, not this organization's reported pay. Based on 2,612 organizations across 2,612 filings (2021 – 2024).
See full Public & Societal Benefit compensation data →Common questions about New England Breast Cancer Alliance
What are New England Breast Cancer Alliance's revenue and expenses?
In 2023, New England Breast Cancer Alliance reported $267k in total revenue and $162k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more